Antimicrobial resistance (AMR) is a major global health problem, exacerbated by the excessive and inappropriate use of antibiotics in human medicine, animal care and agriculture. Therefore, new strategies and compounds are needed to overcome this issue. In this view, it may be appropriate to reconsider existing biomaterials to alleviate antibiotic overuse. Chitin, a naturally abundant amino mucopolysaccharide, is a poly-β-1, 4-N-acetylglucosamine (GlcNAc). It is a white, hard, inelastic, nitrogenous polysaccharide and the major source of surface pollution in coastal areas. Chitosan derives from the partial N-deacetylation of chitin and originates from the shells of crustaceans and the fungi cell walls. It is a nontoxic natural antimicrobial polymer approved by GRAS (Generally Recognized as Safe by the United States Food and Drug Administration). Chitin and chitosan, as non-toxic biopolymers, are useful compounds for wastewater treatment to remove pollutants, such as pharmaceuticals, heavy metals and dyes. The described features make these biopolymers intriguing compounds to be investigated for their application as antibacterials.
The incidence and mortality rates of cardiovascular diseases (CVDs) are constantly increasing. Among the main risk factors, diabetes mellitus and hyperlipidaemia, which are equally widespread pathological conditions, stand out. Current preventive strategies are based on physical activity and a healthy, balanced diet. Primary therapies, on the other hand, are based on the administration of hypoglycaemic and cholesterol-lowering drugs. Given the increasing consumer demand for food products with healthy properties, functional beverages may represent a breakthrough in this field. Through a careful analysis of studies conducted over the past seven years, it has emerged that herbal teas, fruit and vegetable drinks, as well as milk- and plant-based beverages, can mitigate these two critical CVD risk factors, often linked to the presence of specific polyphenols or fermentation processes. The selection of in vivo, in vitro and clinical trials revealed the ability of such drinks to reduce the enzymatic activity of α-glucosidase and α-amylase, as well as to decrease circulating lipid levels, properties that were surprisingly also exhibited by beverages derived from food waste. Therefore, this review aims to highlight the possibility of employing these drinks as adjuvant therapy in the treatment of diabetes mellitus and hyperlipidaemia in order to reduce two potential CVD risk factors.
High-methoxyl pectin, functionalised with phenolic compounds extracted from coffee silverskin, was used in chicken meatballs formulation for improving antioxidant and sensory properties of the final product. An enzymatic conjugation process was applied to obtain the functional pectin then added at the level of 2.5%. At the same time, non-spiked chicken meatballs were prepared as control. At day 0, functionalised meatballs (PLF0) exhibited a total polyphenol content of 10.44 mg GAE per g, significantly higher than controls (PB, 2.74 mg GAE per g). Antioxidant capacity, expressed as IC30 against the ABTS˙+ radical, was 0.0127 mg mL−1 in PLF0 compared to 0.8982 mg mL−1 in PB0. After 5 and 10 days of storage at +4 °C, functionalised samples retained markedly higher antioxidant potential, with IC30 values nearly 9-fold lower than PB5 and 14-fold lower than PB10, respectively. Cooking preserved these benefits: PLFC maintained a TPC of 9.33 mg GAE per g and an IC30 of 0.1129 mg mL−1, while controls showed lower TPC (5.54 mg GAE per g) and weaker activity (1.4920 mg mL−1). Sensory evaluation revealed that the incorporation of functionalised pectin did not adversely affect the visual appearance, odor, or texture of chicken meatballs. Both raw and cooked products maintained comparable acceptability to controls, with no significant differences in overall liking. Notably, the functionalised meatballs retained their characteristic sensory profile after 10 days of refrigerated storage, confirming that the enrichment with coffee silverskin-derived conjugates did not impair consumer-relevant attributes. Overall, these results demonstrated that functionalisation of chicken meatballs with coffee silverskin extract enhanced the polyphenol content and the antioxidant stability while preserving desirable sensory qualities, making this approach a promising strategy for developing antioxidant-enriched meat products.
Background: Antimicrobial resistance (AMR) represents a global health challenge, contributing to elevated rates of morbidity and mortality. This growing problem is attributed to the widespread and indiscriminate use of antimicrobial agents. In response, current research is focused on identifying novel strategies to combat AMR, with particular attention to alternative therapeutic agents. Natural antimicrobials have emerged as promising candidates. Among these, wheat, one of the most cultivated food crops in the world, is identified as a valuable source of such bioactive compounds. Beyond its nutritional importance and prevalent use in food production, wheat is rich in polyphenols, small peptides, benzoxazinoids, 1,4-benzoquinones, and 5-n-alkylresorcinols. In vitro investigations have demonstrated that these phytochemicals possess broad-spectrum antimicrobial activities, exhibiting efficacy against Gram–positive and Gram–negative bacteria, as well as various fungi. Methods: Two databases, i.e., Google Scholar and Scopus, were screened using different keywords. Results: A series of key compounds responsible for these effects were identified, evaluating wheat’s potential role as a sustainable source of novel and potent antimicrobial agents. Conclusions: This review aims to collect the latest findings regarding the antimicrobial potential of different wheat varieties and their by-products.
Urolithin A (Uro A) is a natural bioactive compound biosynthesized by the gut microbiota after the ingestion of foods that are rich in ellagic acid and ellagitannins, such as strawberries, pomegranate, raspberries and walnuts. Uro A is studied in preclinical and clinical studies for its numerous biological activities, including antioxidant, anti-inflammatory, anticancer, cardioprotective and neuroprotective properties, while also possessing a therapeutic potential against metabolic syndrome and mitochondrial-enhancing effects. This narrative review briefly outlines the biosynthesis of Uro A and current evidence on its biological properties and its potential role in mitigating diseases, on the basis of literature searches performed on Google Scholar, Scopus, and PubMed/MEDLINE. In addition, recent clinical trials based on the supplementation with Uro A are summarized herein.